ЭFFICACY AND TOLERABILITY OF LENVATINIB IN RADIOIODINE-REFRACTORY DIFFERENTIATED THYROID CANCER

ЭFFICACY AND TOLERABILITY OF LENVATINIB IN RADIOIODINE-REFRACTORY DIFFERENTIATED THYROID CANCER

Authors

  • Tillyashaikhov M. N Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology of the Ministry of Health of the Republic of Uzbekistan,
  • Khakimov G. A Tashkent City Branch of the Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology of the Ministry of Health of the Republic of Uzbekistan
  • Abdurakhimov O. N Tashkent City Branch of the Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology of the Ministry of Health of the Republic of Uzbekistan
  • Malikov M. A Tashkent City Branch of the Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology of the Ministry of Health of the Republic of Uzbekistan

Keywords:

To analyze the aggregated clinical, lenvatinib, radioiodine-refractory thyroid cancer, clinical practice

Abstract

The introduction of tyrosine kinase inhibitors into clinical practice has significantly improved treatment outcomes for patients with radioiodine-refractory differentiated thyroid cancer (RR-DTC). Lenvatinib is recommended as a first-line drug for this category of patients

Downloads

Published

2024-06-10

How to Cite

ЭFFICACY AND TOLERABILITY OF LENVATINIB IN RADIOIODINE-REFRACTORY DIFFERENTIATED THYROID CANCER. (2024). Western European Journal of Medicine and Medical Science, 2(6), 11-20. https://westerneuropeanstudies.com/index.php/3/article/view/1131

Issue

Section

Articles

How to Cite

ЭFFICACY AND TOLERABILITY OF LENVATINIB IN RADIOIODINE-REFRACTORY DIFFERENTIATED THYROID CANCER. (2024). Western European Journal of Medicine and Medical Science, 2(6), 11-20. https://westerneuropeanstudies.com/index.php/3/article/view/1131

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >> 

Similar Articles

41-50 of 55

You may also start an advanced similarity search for this article.

Loading...